2S [LEC]: Antihuman Globulin Test Flashcards
In 1908, which scientist described the principle of the AHG test?
Moreschii
In 1945, which scientist described the use of the antiglobulin test for the detection of weak and non-agglutinating Rh antibodies in the serum?
Robert Russell Race
In 1946, which scientist described the used of AHG to detect in vivo sensitization of the RBCs of babies suffering from HDN?
Coombs
The AHG reagent is composed of red cells sensitized by what?
IgG or C’ proteins (C3b or C3d)
The monoclonal antibody technique was devised by ___
Kohler and Milstein
Sample of choice for DAT
EDTA blood
Complement-dependent antibodies will not be detected when which specimen is used?
Plasma
Which reagent negates the in-vitro activation of the complement pathway?
EDTA
What would be the effect when an in vivo sensitization results to recipient antibody coating donor RBCs?
Hemolytic Transfusion Reaction (HTR)
Immune-mediated red cell destruction leading to anemia is a result when transfusion still proceeded in a positive test for which method?
DAT
Test employed to diagnose Paroxysmal Cold Hemoglobinuria
Donath Landsteiner Test
DAT result if a patient is positive for autoantibody
Positive
What would be the effect when an in vivo sensitization results to maternal antibody coating fetal RBCs?
HDFN
What would be the effect when an in vivo sensitization results to autoantibody coating individual’s RBC?
AIHA
Identify the type of drug-induced phenomena associated with a positive DAT:
Drug binds covalently to membrane proteins and stimulates hapten-dependent Ab
Type I (hapten-dependent Ab)
Identify the type of drug-induced phenomena associated with a positive DAT:
Drug induces autoantibody specific for RBC membrane proteins through unknown mechanism
Type II (Autoantibody)
Identify the type of drug-induced phenomena associated with a positive DAT:
Ab reacts with normal RBCs in the absence of drug
Type II (Autoantibody)
Identify the type of drug-induced phenomena associated with a positive DAT:
Drug induces Ab that binds to RBC only when drug is present in soluble form, unknown mechanism
Type III (drug-dependent Ab)
Identify the type of drug-induced phenomena associated with a positive DAT:
Ab reacts with normal RBCs when soluble drug is present
Type III (drug-dependent Ab)
Samples used in IAT
Red cell or serum
Procedure that detects antibodies with specificity to red cell antigens
Antibody screening
Procedure that identifies specificity of red cell antibodies
Antibody identification
Procedure that determines serologic compatibility between donor and patient before transfusion
Crossmatch
Procedure that identifies a specific red cell antigen in a patient or donor
Antigen typing